These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1833124)

  • 1. Bedside blood ketone body monitoring.
    McBride MO; Smye M; Nesbitt GS; Hadden DR
    Diabet Med; 1991; 8(7):688-90. PubMed ID: 1833124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring therapy with insulin in ketoacidotic patients by quantifying 3-hydroxybutyrate with a commercial kit.
    Mercer DW; Losos FJ; Mason L; Kessler GF
    Clin Chem; 1986 Jan; 32(1 Pt 1):224-5. PubMed ID: 3079681
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical utility of beta-hydroxybutyrate determined by reflectance meter in the management of diabetic ketoacidosis.
    Umpierrez GE; Watts NB; Phillips LS
    Diabetes Care; 1995 Jan; 18(1):137-8. PubMed ID: 7698038
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of diabetic ketoacidosis using normalization of blood 3-hydroxybutyrate concentration as the endpoint of emergency management. A randomized controlled study.
    Wiggam MI; O'Kane MJ; Harper R; Atkinson AB; Hadden DR; Trimble ER; Bell PM
    Diabetes Care; 1997 Sep; 20(9):1347-52. PubMed ID: 9283776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxybutyrate near-patient testing to evaluate a new end-point for intravenous insulin therapy in the treatment of diabetic ketoacidosis in children.
    Noyes KJ; Crofton P; Bath LE; Holmes A; Stark L; Oxley CD; Kelnar CJ
    Pediatr Diabetes; 2007 Jun; 8(3):150-6. PubMed ID: 17550425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bedside monitoring of blood beta-hydroxybutyrate levels in the management of diabetic ketoacidosis in children.
    Rewers A; McFann K; Chase HP
    Diabetes Technol Ther; 2006 Dec; 8(6):671-6. PubMed ID: 17109599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma immunoreactive somatostatin is elevated in diabetic ketoacidosis and correlates with plasma non-esterified fatty acid concentration.
    Binimelis J; Webb SM; Serrano J; Codina M; Corcoy R; Perez A; Peinado MA; Puig M; de la Torre W; Serrat J
    Diabet Med; 1987; 4(3):221-4. PubMed ID: 2886248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cerebrospinal fluid in diabetic ketoacidosis.
    Ohman JL; Marliss EB; Aoki TT; Munichoodappa CS; Khanna VV; Kozak GP
    N Engl J Med; 1971 Feb; 284(6):283-90. PubMed ID: 4992715
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased serum D-lactate associated with diabetic ketoacidosis.
    Christopher MM; Broussard JD; Fallin CW; Drost NJ; Peterson ME
    Metabolism; 1995 Mar; 44(3):287-90. PubMed ID: 7885271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood lactate and ketone bodies in diabetic ketoacidosis.
    Strandgaard S; Nielsen PE; Bitsch V; Lyngsoe J
    Acta Med Scand; 1971; 190(1-2):17-20. PubMed ID: 4999785
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of efficacy of human and porcine insulin in treatment of diabetic ketoacidosis.
    Storms FE; Lutterman JA; van't Laar A
    Diabetes Care; 1987; 10(1):49-55. PubMed ID: 3105986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-hydroxybutyrate and acetoacetate levels.
    Foreback CC
    Am J Clin Pathol; 1997 Nov; 108(5):602-4. PubMed ID: 9353103
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of combined insulin and somatostatin infusion for the treatment of experimental diabetic ketoacidosis.
    Harano Y; Ohgaku S; Hidaka H; Takatsuki K; Shigeta Y
    Horm Metab Res; 1979 May; 11(5):338-42. PubMed ID: 113327
    [No Abstract]   [Full Text] [Related]  

  • 14. Can beta-hydroxybutyrate be detected at the bedside by in vitro oxidation with hydrogen peroxide.
    Oster JR; Rietberg B; Taylor AL; Perez GO; Chandra R; Gardner LB
    Diabetes Care; 1984; 7(1):80-2. PubMed ID: 6423353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic measurement of the combined concentrations of acetoacetate and beta-hydroxybutyrate in serum.
    Nuwayhid NF; Johnson GF; Feld RD
    Clin Chem; 1988 Sep; 34(9):1790-3. PubMed ID: 3138043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme in diabetes mellitus dependence on metabolic aberration.
    Schmitz O; Rømer FK; Alberti KG; Hreidarsson AB; Orskov H
    Diabete Metab; 1983 Sep; 9(3):179-82. PubMed ID: 6317477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic ketoacidosis: not always due to type 1 diabetes.
    Misra S; Oliver N; Dornhorst A
    BMJ; 2013 Jun; 346():f3501. PubMed ID: 23751904
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship of blood acetoacetate and 3-hydroxybutyrate in diabetes.
    Stephens JM; Sulway MJ; Watkins PJ
    Diabetes; 1971 Jul; 20(7):485-9. PubMed ID: 4997333
    [No Abstract]   [Full Text] [Related]  

  • 19. Laboratory and clinical evaluation of assays for beta-hydroxybutyrate.
    Porter WH; Yao HH; Karounos DG
    Am J Clin Pathol; 1997 Mar; 107(3):353-8. PubMed ID: 9052387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose intravenous insulin infusion in patients with diabetic ketoacidosis: biochemical effects in children.
    Lightner ES; Kappy MS; Revsin B
    Pediatrics; 1977 Nov; 60(5):681-8. PubMed ID: 411105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.